97 related articles for article (PubMed ID: 32787735)
1. Ikaros is heterogeneously expressed in lung adenocarcinoma and is involved in its progression.
Zhao W; Chen TB; Wang H
J Int Med Res; 2020 Aug; 48(8):300060520945860. PubMed ID: 32787735
[TBL] [Abstract][Full Text] [Related]
2. A Clinicopathological Study of Small Lung Adenocarcinoma 1 cm or Less in Size: Emphasis on Histological Subtypes Associated With Lymph Node Metastasis and Recurrence.
Zhao W; Wang H; Xie J; Tian B
Int J Surg Pathol; 2018 Feb; 26(1):4-11. PubMed ID: 28805108
[TBL] [Abstract][Full Text] [Related]
3. IMP3 expression is correlated with histologic grade of lung adenocarcinoma.
Findeis-Hosey JJ; Yang Q; Spaulding BO; Wang HL; Xu H
Hum Pathol; 2010 Apr; 41(4):477-84. PubMed ID: 20004948
[TBL] [Abstract][Full Text] [Related]
4. A different TRAP220 expression in distinct histologic subtypes of lung adenocarcinoma and the prognostic significance.
Yun J; Son CH; Um SJ; Kwon HC; Lee KE; Choi PJ; Roh MS
Lung Cancer; 2011 Mar; 71(3):312-8. PubMed ID: 20650541
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between histopathologic characteristics and epidermal growth factor receptor mutation in lung adenocarcinoma].
Wang K; Gong H; Li X; Yang Z; Cao P; Wand C; Jiang Y; Wang H; Wang Y; Zhang G
Zhonghua Bing Li Xue Za Zhi; 2015 Mar; 44(3):170-4. PubMed ID: 26268750
[TBL] [Abstract][Full Text] [Related]
6. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
[TBL] [Abstract][Full Text] [Related]
8. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.
Eguchi T; Kadota K; Park BJ; Travis WD; Jones DR; Adusumilli PS
Semin Thorac Cardiovasc Surg; 2014; 26(3):210-22. PubMed ID: 25527015
[TBL] [Abstract][Full Text] [Related]
9. Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.
Sakurai H; Asamura H; Miyaoka E; Yoshino I; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
Eur J Cardiothorac Surg; 2014 Jan; 45(1):100-7. PubMed ID: 23729748
[TBL] [Abstract][Full Text] [Related]
10. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension.
Lin MW; Wu CT; Shih JY; Chang YL; Yang PC
J Surg Oncol; 2014 Aug; 110(2):99-106. PubMed ID: 24788590
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of PD-L1 Protein Expression in Surgically Resected Primary Lung Adenocarcinoma.
Takada K; Okamoto T; Shoji F; Shimokawa M; Akamine T; Takamori S; Katsura M; Suzuki Y; Fujishita T; Toyokawa G; Morodomi Y; Okano S; Oda Y; Maehara Y
J Thorac Oncol; 2016 Nov; 11(11):1879-1890. PubMed ID: 27346415
[TBL] [Abstract][Full Text] [Related]
13. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
[No Abstract] [Full Text] [Related]
15. Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations.
Saruwatari K; Ikemura S; Sekihara K; Kuwata T; Fujii S; Umemura S; Kirita K; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Ochiai A; Kohrogi H; Tsuboi M; Goto K; Ishii G
Lung Cancer; 2016 Jan; 91():7-14. PubMed ID: 26711928
[TBL] [Abstract][Full Text] [Related]
16. Up-Regulation of S100A11 in Lung Adenocarcinoma - Its Potential Relationship with Cancer Progression.
Woo T; Okudela K; Mitsui H; Tajiri M; Rino Y; Ohashi K; Masuda M
PLoS One; 2015; 10(11):e0142642. PubMed ID: 26544866
[TBL] [Abstract][Full Text] [Related]
17. Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.
Hong SJ; Kim TJ; Choi YW; Park JS; Chung JH; Lee KW
Eur Radiol; 2016 Oct; 26(10):3660-8. PubMed ID: 26787602
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic characteristics of lung adenocarcinomas with epidermal growth factor receptor mutations in the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification.
Shim HS; Lee DH; Park EJ; Kim SH
Arch Pathol Lab Med; 2011 Oct; 135(10):1329-34. PubMed ID: 21970488
[TBL] [Abstract][Full Text] [Related]
19. Ectopic Ikaros expression positively correlates with lung cancer progression.
Zhang Z; Xu Z; Wang X; Wang H; Yao Z; Mu Y; Ma Z; Liu Z
Anat Rec (Hoboken); 2013 Jun; 296(6):907-13. PubMed ID: 23580163
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of pulmonary adenocarcinoma.
Kawai T; Torikata C; Suzuki M
Am J Clin Pathol; 1988 Apr; 89(4):455-62. PubMed ID: 2451418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]